Full Coverage

FDA approves Entereg (alvimopan) to restore bowel function

View first page of story coverage
RELATED
Found 31 documents:
                   

Adolor and GlaxoSmithKline Announce FDA Approval of Entereg(R) (alvimopan) for the Management of...

wallstreet-online.de
May 20, 2008
        

Adolor Corporation and GlaxoSmithKline (NYSE:GSK) announced today that the U.S. Food and Drug Administration has approved Entereg(R) (alvimopan) capsules to help patients regain gastrointestinal (GI) function earlier following bowel resection surgery. "The approval of Entereg in POI represents a...